← Leaderboards
Robert E Richard
University Of Washington
$761,265
Attributed
$761,265
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $152.3K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$761,265 · 1
By mechanism
K23$761,265 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Thalia Papayannopoulou$16,580,758
- Andre Michael Lieber$20,253,196
- David W Russell$27,160,623
- Thomas A Reh$17,988,348
- C. Anthony Blau$17,614,130
Others in their field
Top investigators on “Nod Mouse”
- Betty Diamond · Feinstein Institute For Medical Research$17,429,471
- Richard J Ulevitch · Scripps Research Institute$15,527,803
- David V. Serreze · Jackson Laboratory$15,338,986
- Emil R Unanue · Washington University$14,838,488
- Luc Teyton · Scripps Research Institute, The$13,032,555
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
Research focus
Nod MouseDisease /Disorder ModelThrombopoietic FactorTransfection /Expression VectorScid MouseDimerGene TherapyGenetic ManipulationGrowth Factor ReceptorsGrowth MediaHematopoietic Stem CellsHematopoietic Tissue TransplantationHuman SubjectHuman Therapy EvaluationHydroxyureaPatient Oriented ResearchRetroviridaeSample CollectionSickle Cell AnemiaStem Cell TransplantationBone MarrowXenotransplantationCd34 MoleculeChimeric Proteins
Grant awards (5)
CONDITIONAL ACTIVATION OF MPL AS A GENE THERAPY STRATEGY$152,253
K23 · FY2006 · RR · contact PI
CONDITIONAL ACTIVATION OF MPL AS A GENE THERAPY STRATEGY$152,253
K23 · FY2005 · RR
CONDITIONAL ACTIVATION OF MPL AS A GENE THERAPY STRATEGY$152,253
K23 · FY2004 · RR
CONDITIONAL ACTIVATION OF MPL AS A GENE THERAPY STRATEGY$152,253
K23 · FY2003 · RR
CONDITIONAL ACTIVATION OF MPL AS A GENE THERAPY STRATEGY$152,253
K23 · FY2002 · RR